03 June 2014, the State Service of Ukraine on Medicinal Products conducted the audit of Farmak’s new Soft Gelatin Capsules (SGCs) Manufacturing Site, which is to be launched due to expansion of the Company’s operations. This will be the 18th manufacturing site of the Company.
The audit findings confirmed that the SGC Manufacturing Site is compliant with the requirements of the manufacture licensing law.
On 06 June 2014, the State Service of Ukraine on Medicinal Products made a decision to revise Farmak’s current license in order to authorize manufacture of a new dosage form: Soft Gelatin Capsules.
The cost of Soft Gelatin Capsules project amounted approximately to UAH 22 million. A third of the investments was spent to purchase the production equipment.
Deputy Technical Director, Head of Investment and Development Department, Oleksandr Bogachuk, says, “At the moment, we launch manufacturing of the pilot batches on the SGC Manufacture Site. The manufacture and sales of the medicinal products in Soft Gelatin Capsule dosage form are planned to be started in Ukrainian market at the end of 2014. The site production capacity is expected to be about 240 million capsules per year.
Farmak, as a member of the European Generic Medicines Association (EGA) – Medicines for Europe – and the Association of “Manufacturers of Drugs of Ukraine” (the AMDU), advocates for the creation of a coordination group at the Office of the President of Ukraine to prevent a shortage of medicines in Ukraine during the pandemic. […]
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]